Braveheart Bio, Inc.

BRVE chart

Braveheart Bio, Inc. news

• Braveheart Bio to present at Jefferies Global H...

  Pluang · Nov 9, 7:43 AM EST

• Braveheart Bio to Participate in the Jefferies Global Healthcare Conference in London

  Yahoo Finance · Nov 9, 7:30 AM EST

• One investor reports sole voting power over 7.42M Braveheart Bio (BRVE) shares.

  Stock Titan · Nov 9, 6:05 AM EST

• Braveheart Bio (Nasdaq:BRVE) - Stock Analysis

  Simply Wall St · Nov 8, 2:04 PM EST

• Braveheart Bio, Inc. (BRVE) stock price, news, quote and history

  Yahoo Finance UK · Nov 7, 11:48 AM EST

• BRVE: Braveheart Bio Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

  Quantisnow · Nov 7, 4:59 AM EST

• Braveheart Bio, Inc. (BRVE) Stock Price, News, Quote & History

  Yahoo! Finance Canada · Nov 7, 3:01 AM EST

• Braveheart Bio Shares One-Year Heart Drug Data, Plans New Fixed-Dose Trial

  marketbeat.com · Nov 6, 8:14 PM EST

• Braveheart Bio, Inc. (BRVE) Shareholder/Analyst Call - Slideshow (NASDAQ:BRVE) 2026-11-06

  Seeking Alpha · Nov 6, 8:04 PM EST

• Braveheart Bio Reports Positive 52-Week HCM Study Data

  TipRanks · Nov 6, 4:34 PM EST

• Hengrui Pharma and Braveheart Bio Present Data from 52-Week...

  Quantisnow · Nov 6, 3:45 PM EST

• Form 8K Braveheart Bio For: 6 November By Investing.com

  Investing.com Canada · Nov 6, 3:33 PM EST

Braveheart Bio, Inc. key financials

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 8-K8-K2026-11-06
• 10-Q10-Q2026-09-08
• 8-K8-K2026-09-08
• 8-K8-K2026-08-07
• S-1S-12026-07-15

About Braveheart Bio, Inc.

Ticker

BRVE (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

San Francisco, CA

Incorporated in

DE

Fiscal year end

December 31

SEC CIK

2131524

Frequently asked questions